Arcturus Therapeutics Holdings Inc. (ARCT) intrinsic value & 10-year financials
Arcturus Therapeutics Holdings Inc. (ARCT) has a Graham intrinsic value of $11.63 per share. At $10.34 on Oct 17, 2026, the stock trades 11% below that value. Over the last 9 fiscal years revenue grew 26.6% a year to $82.0M, with an average return on invested capital of 100.4%.
- Graham intrinsic value
- $11.63
- Share price (Oct 17, 2026)
- $10.34
- Price vs Graham value
- 11% below
- Market cap
- $283.2M
- Revenue (FY2025)
- $82.0M
- Revenue growth (9-yr CAGR)
- 26.6%
- ROIC (10-yr avg)
- 100.4%
- Free cash flow (FY2025)
- -$74.5M
ARCT 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $82.0M | -$65.8M | -$2.40 | -$74.5M | -93.0% | -401.0% |
| FY2024 | $152.3M | -$80.9M | -$3.00 | -$60.4M | -62.8% | -462.6% |
| FY2023 | $166.8M | -$29.7M | -$1.12 | -$21.0M | -46.9% | 855.4% |
| FY2022 | $206.0M | $9.3M | $0.35 | $24.3M | 5.9% | -20.3% |
| FY2021 | $12.4M | -$203.7M | -$7.74 | -$138.4M | -1641.3% | 334.2% |
| FY2020 | $9.5M | -$72.1M | — | -$44.6M | -749.8% | 197.8% |
| FY2019 | $20.8M | -$26.0M | — | -$7.3M | -122.7% | 133.7% |
| FY2018 | $15.8M | -$21.8M | — | -$22.2M | -138.5% | 165.6% |
| FY2017 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Arcturus Therapeutics Holdings Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Arcturus Therapeutics Holdings Inc. returns on capital have been average, hovering around 15.0% ROIC over the decade.
Arcturus Therapeutics Holdings Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Arcturus Therapeutics Holdings Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $11.63 per share.